PRECIGEN, INC. Depreciation
PRECIGEN, INC. (PGEN) reported Depreciation of $782.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-04
- PRECIGEN, INC. depreciation for the quarter ending 2026-06-30 was $782.00K, a 150.64% increase year-over-year.
- PRECIGEN, INC. depreciation for the quarter ending 2026-03-31 was $781.00K, a 151.94% increase year-over-year.
- PRECIGEN, INC. depreciation for the quarter ending 2025-12-31 was $819.00K, a 138.78% increase year-over-year.
- PRECIGEN, INC. depreciation for the quarter ending 2025-09-30 was $485.00K, a 36.24% increase year-over-year.
- PRECIGEN, INC. depreciation for fiscal 2025 was $1.93M, a 31.29% increase from fiscal 2024.
- PRECIGEN, INC. depreciation for fiscal 2024 was $1.47M, a 19.40% decline from fiscal 2023.
- PRECIGEN, INC. depreciation for fiscal 2023 was $1.82M, a 23.94% decline from fiscal 2022.
- PRECIGEN, INC. depreciation for fiscal 2022 was $2.39M, a 16.50% decline from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $782.00K 10-Q · filed 2026-08-04 | $1.56M 10-Q · filed 2026-08-04 | $2.38M derived: sum of 3 quarters · filed 2026-08-04 | $2.87M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $781.00K 10-Q · filed 2026-05-13 | $1.60M derived: sum of 2 quarters · filed 2026-05-13 | $2.08M derived: sum of 3 quarters · filed 2026-05-13 | $2.40M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $819.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.30M derived: sum of 2 quarters · filed 2026-03-25 | $1.62M derived: sum of 3 quarters · filed 2026-08-04 | $1.93M 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | $485.00K 10-Q · filed 2025-11-13 | $797.00K derived: sum of 2 quarters · filed 2026-08-04 | $1.11M 10-Q · filed 2025-11-13 | $1.45M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $312.00K 10-Q · filed 2026-08-04 | $622.00K 10-Q · filed 2026-08-04 | $965.00K derived: sum of 3 quarters · filed 2026-08-04 | $1.32M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $310.00K 10-Q · filed 2026-05-13 | $653.00K derived: sum of 2 quarters · filed 2026-05-13 | $1.01M derived: sum of 3 quarters · filed 2026-05-13 | $1.40M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $343.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $699.00K derived: sum of 2 quarters · filed 2026-03-25 | $1.09M derived: sum of 3 quarters · filed 2026-03-25 | $1.47M 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | $356.00K 10-Q · filed 2025-11-13 | $744.00K derived: sum of 2 quarters · filed 2025-11-13 | $1.12M 10-Q · filed 2025-11-13 | $1.53M derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2024-06-30 | $388.00K 10-Q · filed 2025-08-12 | $768.00K 10-Q · filed 2025-08-12 | $1.17M derived: sum of 3 quarters · filed 2026-03-25 | $1.61M derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2024-03-31 | $380.00K 10-Q · filed 2025-05-14 | $785.00K derived: sum of 2 quarters · filed 2026-03-25 | $1.22M derived: sum of 3 quarters · filed 2026-03-25 | $1.69M derived: sum of 4 quarters · filed 2026-03-25 | ||||
| 2023-12-31 | $405.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $839.00K derived: sum of 2 quarters · filed 2026-03-25 | $1.31M derived: sum of 3 quarters · filed 2026-03-25 | $1.82M 10-K · filed 2026-03-25 | ||||
| 2023-09-30 | $434.00K 10-Q · filed 2024-11-14 | $909.00K derived: sum of 2 quarters · filed 2024-11-14 | $1.42M 10-Q · filed 2024-11-14 | $1.98M derived: sum of 4 quarters · filed 2025-03-19 | ||||
| 2023-06-30 | $475.00K 10-Q · filed 2024-08-14 | $981.00K 10-Q · filed 2024-08-14 | $1.54M derived: sum of 3 quarters · filed 2025-03-19 | $2.10M derived: sum of 4 quarters · filed 2025-03-19 | ||||
| 2023-03-31 | $506.00K 10-Q · filed 2024-05-14 | $1.07M derived: sum of 2 quarters · filed 2025-03-19 | $1.63M derived: sum of 3 quarters · filed 2025-03-19 | $2.25M derived: sum of 4 quarters · filed 2025-03-19 | ||||
| 2022-12-31 | $560.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19 | $1.12M derived: sum of 2 quarters · filed 2025-03-19 | $1.74M derived: sum of 3 quarters · filed 2025-03-19 | $2.39M 10-K · filed 2025-03-19 | ||||
| 2022-09-30 | $564.00K 10-Q · filed 2023-11-09 | $1.18M derived: sum of 2 quarters · filed 2023-11-09 | $1.83M 10-Q · filed 2023-11-09 | $2.52M derived: sum of 4 quarters · filed 2024-03-19 | ||||
| 2022-06-30 | $616.00K 10-Q · filed 2023-08-09 | $1.27M 10-Q · filed 2023-08-09 | $1.95M derived: sum of 3 quarters · filed 2024-03-19 | $2.69M derived: sum of 4 quarters · filed 2024-03-19 | ||||
| 2022-03-31 | $653.00K 10-Q · filed 2023-05-10 | $1.48M 10-Q · filed 2022-05-09 | $1.33M derived: sum of 2 quarters · filed 2024-03-19 | $2.07M derived: sum of 3 quarters · filed 2024-03-19 | $2.80M derived: sum of 4 quarters · filed 2024-03-19 | |||
| 2021-12-31 | $682.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $1.42M derived: sum of 2 quarters · filed 2024-03-19 | $2.15M derived: sum of 3 quarters · filed 2024-03-19 | $2.87M 10-K · filed 2024-03-19 | $6.20M 10-K · filed 2022-03-01 | |||
| 2021-09-30 | $735.00K 10-Q · filed 2022-11-09 | $1.52M 10-Q · filed 2021-11-08 | $1.47M derived: sum of 2 quarters · filed 2022-11-09 | $2.18M 10-Q · filed 2022-11-09 | $4.71M 10-Q · filed 2021-11-08 | $422.00K derived: sum of 4 quarters · filed 2023-03-06 | ||
| 2021-06-30 | $734.00K 10-Q · filed 2022-08-08 | $1.59M 10-Q · filed 2021-08-09 | $1.47M 10-Q · filed 2022-08-08 | $3.19M 10-Q · filed 2021-08-09 | -$313.00K derived: sum of 3 quarters · filed 2023-03-06 | $1.56M derived: sum of 4 quarters · filed 2023-03-06 | ||
| 2021-03-31 | $1.59M 10-Q · filed 2022-05-09 | -$1.05M derived: sum of 2 quarters · filed 2023-03-06 | $826.00K derived: sum of 3 quarters · filed 2023-03-06 | $2.72M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2020-12-31 | -$2.64M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$767.00K derived: sum of 2 quarters · filed 2023-03-06 | $1.13M derived: sum of 3 quarters · filed 2023-03-06 | $3.05M 10-K · filed 2023-03-06 | $7.45M 10-K · filed 2021-03-01 | |||
| 2020-09-30 | $1.87M 10-Q · filed 2021-11-08 | $2.19M 10-Q · filed 2020-11-09 | $3.77M derived: sum of 2 quarters · filed 2021-11-08 | $5.69M 10-Q · filed 2021-11-08 | $8.03M 10-Q · filed 2020-11-09 | $4.93M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-30 | $1.90M 10-Q · filed 2021-08-09 | $2.90M 10-Q · filed 2020-08-10 | $3.82M 10-Q · filed 2021-08-09 | $5.83M 10-Q · filed 2020-08-10 | $3.05M derived: sum of 3 quarters · filed 2022-03-01 | $5.93M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-31 | $1.92M 10-Q · filed 2021-05-10 | $2.93M 10-Q · filed 2020-05-11 | $1.16M derived: sum of 2 quarters · filed 2022-03-01 | $4.03M derived: sum of 3 quarters · filed 2022-03-01 | $6.96M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | -$762.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $2.11M derived: sum of 2 quarters · filed 2022-03-01 | $5.04M derived: sum of 3 quarters · filed 2022-03-01 | $8.22M 10-K · filed 2022-03-01 | $11.87M 10-K · filed 2020-03-02 | |||
| 2019-09-30 | $2.87M 10-Q · filed 2020-11-09 | $3.29M 10-Q · filed 2019-11-12 | $5.81M derived: sum of 2 quarters · filed 2020-11-09 | $8.98M 10-Q · filed 2020-11-09 | $10.21M 10-Q · filed 2019-11-12 | $7.22M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-06-30 | $2.93M 10-Q · filed 2020-08-10 | $3.35M 10-Q · filed 2019-08-09 | $6.11M 10-Q · filed 2020-08-10 | $6.92M 10-Q · filed 2019-08-09 | $4.34M derived: sum of 3 quarters · filed 2021-03-01 | $7.96M derived: sum of 4 quarters · filed 2021-03-01 | ||
| 2019-03-31 | $3.18M 10-Q · filed 2020-05-11 | $3.57M 10-Q · filed 2019-05-09 | $1.41M derived: sum of 2 quarters · filed 2021-03-01 | $5.03M derived: sum of 3 quarters · filed 2021-03-01 | $8.67M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2018-12-31 | -$1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $1.85M derived: sum of 2 quarters · filed 2021-03-01 | $5.49M derived: sum of 3 quarters · filed 2021-03-01 | $8.95M 10-K · filed 2021-03-01 | $14.33M 10-K · filed 2019-03-01 | |||
| 2018-09-30 | $3.61M 10-Q · filed 2019-11-12 | $7.26M derived: sum of 2 quarters · filed 2019-11-12 | $10.71M 10-Q · filed 2019-11-12 | $12.23M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-06-30 | $3.64M 10-Q · filed 2019-08-09 | $7.10M 10-Q · filed 2019-08-09 | $8.61M derived: sum of 3 quarters · filed 2020-03-02 | $11.60M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-03-31 | $3.46M 10-Q · filed 2019-05-09 | $4.97M derived: sum of 2 quarters · filed 2020-03-02 | $7.96M derived: sum of 3 quarters · filed 2020-03-02 | $10.81M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2017-12-31 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $4.50M derived: sum of 2 quarters · filed 2020-03-02 | $7.36M derived: sum of 3 quarters · filed 2020-03-02 | $10.14M 10-K · filed 2020-03-02 | $11.95M 10-K · filed 2018-03-01 | |||
| 2017-09-30 | $2.99M 10-Q · filed 2018-11-08 | $5.84M derived: sum of 2 quarters · filed 2018-11-08 | $8.62M 10-Q · filed 2018-11-08 | $11.24M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-06-30 | $2.85M 10-Q · filed 2018-08-13 | $5.63M 10-Q · filed 2018-08-13 | $8.25M derived: sum of 3 quarters · filed 2019-03-01 | $10.58M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2017-03-31 | $2.78M 10-Q/A · filed 2018-08-13 | $5.40M derived: sum of 2 quarters · filed 2019-03-01 | $7.73M derived: sum of 3 quarters · filed 2019-03-01 | $10.04M derived: sum of 4 quarters · filed 2019-03-01 | ||||
| 2016-12-31 | $2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $4.95M derived: sum of 2 quarters · filed 2019-03-01 | $7.25M derived: sum of 3 quarters · filed 2019-03-01 | $9.39M 10-K · filed 2019-03-01 | ||||
| 2016-09-30 | $2.33M 10-Q · filed 2017-11-09 | $4.64M derived: sum of 2 quarters · filed 2017-11-09 | $6.77M 10-Q · filed 2017-11-09 | $8.87M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-06-30 | $2.30M 10-Q · filed 2017-08-09 | $4.44M 10-Q · filed 2017-08-09 | $6.54M derived: sum of 3 quarters · filed 2018-03-01 | $8.53M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-03-31 | $2.13M 10-Q · filed 2017-05-10 | $4.24M derived: sum of 2 quarters · filed 2018-03-01 | $6.22M derived: sum of 3 quarters · filed 2018-03-01 | $8.05M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2015-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $4.09M derived: sum of 2 quarters · filed 2018-03-01 | $5.92M derived: sum of 3 quarters · filed 2018-03-01 | $7.87M 10-K · filed 2018-03-01 | ||||
| 2015-09-30 | $1.99M 10-Q · filed 2016-11-09 | $3.81M derived: sum of 2 quarters · filed 2016-11-09 | $5.77M 10-Q · filed 2016-11-09 | $7.74M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | $1.83M 10-Q · filed 2016-08-09 | $3.78M 10-Q · filed 2016-08-09 | $5.75M derived: sum of 3 quarters · filed 2017-03-01 | $7.56M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | $1.95M 10-Q · filed 2016-05-10 | $3.92M derived: sum of 2 quarters · filed 2017-03-01 | $5.73M derived: sum of 3 quarters · filed 2017-03-01 | $7.01M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | $1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $3.78M derived: sum of 2 quarters · filed 2017-03-01 | $5.06M derived: sum of 3 quarters · filed 2017-03-01 | $6.18M 10-K · filed 2017-03-01 | ||||
| 2014-09-30 | $1.81M 10-Q · filed 2015-11-09 | $3.09M derived: sum of 2 quarters · filed 2015-11-09 | $4.21M 10-Q · filed 2015-11-09 | $5.21M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $1.28M 10-Q · filed 2015-08-10 | $2.40M 10-Q · filed 2015-08-10 | $3.41M derived: sum of 3 quarters · filed 2016-02-29 | $4.46M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $1.12M 10-Q · filed 2015-05-11 | $2.13M derived: sum of 2 quarters · filed 2016-02-29 | $3.18M derived: sum of 3 quarters · filed 2016-02-29 | $4.30M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $2.06M derived: sum of 2 quarters · filed 2016-02-29 | $3.18M derived: sum of 3 quarters · filed 2016-02-29 | $4.33M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | $1.06M 10-Q · filed 2014-11-13 | $2.17M derived: sum of 2 quarters · filed 2014-08-14 | $3.32M 10-Q · filed 2014-11-13 | $4.57M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-06-30 | $1.11M 10-Q · filed 2014-08-14 | $2.26M 10-Q · filed 2014-08-14 | $3.51M derived: sum of 3 quarters · filed 2015-03-02 | $4.82M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-03-31 | $1.15M 10-Q · filed 2014-05-09 | $2.40M derived: sum of 2 quarters · filed 2015-03-02 | $3.71M derived: sum of 3 quarters · filed 2015-03-02 | $4.97M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2012-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $2.56M derived: sum of 2 quarters · filed 2015-03-02 | $3.82M derived: sum of 3 quarters · filed 2015-03-02 | $4.96M 10-K · filed 2015-03-02 | ||||
| 2012-09-30 | $1.31M 10-Q · filed 2013-11-07 | $2.57M derived: sum of 2 quarters · filed 2013-11-07 | $3.71M 10-Q · filed 2013-11-07 | |||||
| 2012-06-30 | $1.26M 10-Q/A · filed 2013-10-21 | $2.40M 10-Q/A · filed 2013-10-21 | ||||||
| 2011-12-31 | $3.08M 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |